Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: A meta-analysis

Psychiatry Research

Volumn 226, Issue 1, 2015, Pages 1-13

  Ahmed, Anthony O ^a,b   Mantini, Andrew M ^b   Fridberg, Daniel J ^c   Buckley, Peter F ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c The University of Chicago   (United States)

Author keywords

BDNF; Neurocognition; Schizophrenia; Val66Met

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ATTENTION; COGNITIVE DEFECT; DISEASE ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; INTELLIGENCE; LANGUAGE ABILITY; LEARNING; MEMORY; META ANALYSIS; PRIORITY JOURNAL; PROBLEM SOLVING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; REVIEW; SCHIZOPHRENIA; COGNITION DISORDERS; GENETICS; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84926214776     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.12.069     Document Type: Review

References (90)

1. Aas M., Haukvik U.K., Djurovic S., Tesli M., Athanasiu L., Bjella T., et al. Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders. Journal of Psychiatric Research 2014, 59:14-21.
2. Ahmed A.O., Bhat I.A. Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets. CNS Drugs 2014, 28(4):301-318.
3. Ahmed A.O., Buckley P.F., Mabe P.A. Latent structure of psychotic experiences in the general population. Acta Psychiatrica Scandinavica 2012, 125(1):54-65.
4. Ahmed A.O., Fridberg D., Hanna M., Buckley P.F. Brain-Derived Neurotrophic Factor and neurocognitive profiles in the psychosis spectrum: findings in bipolar disorder and schizophrenia. Bipolar Disorders: Symptoms, Management, and Risk Factors 2013, Nova Science Publishers, New York. N.B. Moore (Ed.).
5. Ahmed A.O., Green B.A., Goodrum N.M., Doane N.J., Birgenheir D., Buckley P.F. Does a latent class underlie schizotypal personality disorder? Implications for schizophrenia. Journal of Abnormal Psychology 2013, 122(2):475-491.
6. Ahmed A.O., Green B.A., Buckley P.F., McFarland M.E. Taxometric analyses of paranoid and schizoid personality disorders. Psychiatry Research 2012, 196(1):123-132.
7. Ahmed, A.O., Strauss, G.P., Buchanan, R.W., Kirkpatrick, B., Carpenter, W.T., 2015 in press. Are negative symptoms dimensional or categorical? Detection and validation of deficit schizophrenia with taxometric and latent variable mixture models. Schizophrenia Bulletin. http://dx.doi.org/10.1093/schbul/sbu163.
8. Baig, B.J., Whalley, H.C., Hall, J., McIntosh, A.M., Job, D.E., Cunningham-Owens, D.G., Johnstone, E.C., Lawrie, S.M., 2010. Functional magnetic resonance imaging of BDNF val66met polymorphism in unmedicated subjects at high genetic risk of schizophrenia performing a verbal memory task. Psychiatry Research 183, 195-201. http://dx.doi.org/10.1016/j.pscychresns.2010.06.009.
9. Barker P.A. Whither proBDNF?. Nature Neuroscience 2009, 12(2):105-106. 10.1038/nn0209-105.
10. Bax L., 2011. Professional Software for Meta-analysis in Excel Version 2.0.1.4. BiostatXL.
11. Bax L., Yu L.M., Ikeda N., Tsuruta H., Moons K.G.M. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Medical Research Methodology 2006, 6:50.
12. Brietzke E., Mansur R.B., Soczynska J., Powell A.M., McIntyre R.S. A theoretical framework informing research about the role of stress in the pathophysiology of bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 39(1):1-8. 10.1016/j.pnpbp.2012.05.004.
13. Buckley P.F., Mahadik S., Pillai A., Terry A. Neurotrophins and schizophrenia. Schizophrenia Research 2007, 94(1-3):1-11. 10.1016/j.schres.2007.01.025.
14. Buckley P.F., Pillai A., Evans D., Stirewalt E., Mahadik S. Brain derived neurotropic factor in first-episode psychosis. Schizophrenia Research 2007, 91(1-3):1-5. 10.1016/j.schres.2006.12.026.
15. Carlino D., De Vanna M., Tongiorgi E. Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?. Neuroscientist 2013, 19(4):345-353.
16. *Carlino D., Leone E., Di Cola F., Baj G., Marin R., Dinelli G., et al. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia. Journal of Psychiatric Research 2011, 45(2):273-279. 10.1016/j.jpsychires.2010.06.012.
17. Chang H.-A., Lu R.-B., Shy M.-J., Chang C.-C., Lee M.-S., Huang S.-Y. Brain-derived neurotrophic factor Val66Met polymorphism: association with psychopathological symptoms of schizophrenia?. Journal of Neuropsychiatry and Clinical Neurosciences 2009, 21(1):30-37. 10.1176/appi.neuropsych.21.1.30.
18. Chen S.-L., Lee S.-Y., Chang Y.-H., Chen S.-H., Chu C.-H., Wang T.-Y., et al. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2014, 51:99-104.
19. Chen Z.-Y., Patel P.D., Sant G., Meng C.-X., Teng K.K., Hempstead B.L., Lee F.S. Variant brain-derived neurotrophic factor (bdnf) (met66) alters the intracellular trafficking and activity-dependent secretion of wild-type bdnf in neurosecretory cells and cortical neurons. Journal of Neuroscience 2004, 24(18):4401-4411. 10.1523/JNEUROSCI.0348-04.2004.
20. Chen, Z.-Y., Jing, D., Bath, K.G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D.G., Toth, M., Yang, C., McEwen, B.S., Hempstead, B.L., Lee, F.S., 2006. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314, 140-143, http://dx.doi.org/10.1126/science.1129663.
21. Chiaruttini C., Vicario A., Li Z., Baj G., Braiuca P., Wu Y., Lee F.S., Gardossi L., Baraban J.M., Tongiorgi E. Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation. Proceedings of the National Academy of Sciences 2004, 106(38):16481-16486.
22. *Chung S., Chung H.Y., Jung J., Chang J.K., Hong J.P. Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients. Comprehensive Psychiatry 2010, 51(4):367-372. 10.1016/j.comppsych.2009.10.003.
23. Collins A., Koechlin E. Reasoning, learning, and creativity: frontal lobe function and human decision-making. PLoS Biology 2012, 10(3):e1001293. 10.1371/journal.pbio.1001293.
24. *De Azua S.R., Matute C., Stertz L., Mosquera F., Palomino A., De la Rosa I., et al. Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis. BMC Psychiatry 2013, 13(1):1-9.
25. *Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112(2):257-269.
26. Fitzgerald D., Lucas S., Redoblado M.A., Winter V., Brennan J., Anderson J., Harris A. Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics. Australian and New Zealand Journal of Psychiatry 2004, 38(7):501-510. 10.1111/j.1440-1614.2004.01403.x.
27. Frommann I., Pukrop R., Brinkmeyer J., Bechdolf A., Ruhrmann S., Berning J., et al. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early - and additional memory dysfunction in the late - prodromal state. Schizophrenia Bulletin 2011, 37(4):861-873. 10.1093/schbul/sbp155.
28. Fuchikami M., Morinobu S., Kurata A., Yamamoto S., Yamawaki S. Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. International Journal of Neuropsychopharmacology 2009, 12(1):73-82. 10.1017/S1461145708008997.
29. Gama C.S., Canever L., Panizzutti B., Gubert C., Stertz L., Massuda R., et al. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophrenia Research 2012, 141(2-3):162-167. 10.1016/j.schres.2012.08.002.
30. Goto N., Yoshimura R., Kakeda S., Moriya J., Hayashi K., Ikenouchi-Sugita A., et al. Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls. European Psychiatry 2011, 26(1):57-63. 10.1016/j.eurpsy.2009.10.001.
31. Gratacòs, M., González, J.R., Mercader, J.M., de Cid, R., Urretavizcaya, M., Estivill, X., 2007. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 61, 911-922. http://dx.doi.org/10.1016/j.biopsych.2006.08.025.
32. Green M.F., Nuechterlein K.H. Should schizophrenia be treated as a neurocognitive disorder?. Schizophrenia Bulletin 1999, 25(2):309-319.
33. Gray, J.A., Roth, B.L., 2007. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophrenia Bull 33, 1100-1119. http://dx.doi.org/10.1093/schbul/sbm074.
34. Green M.J., Matheson S.L., Shepherd A., Weickert C.S., Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Molecular Psychiatry 2011, 16(9):960-972. 10.1038/mp.2010.88.
35. Griffin É.W., Mullally S., Foley C., Warmington S.A., O'Mara S.M., Kelly A.M. Aerobic exercise improves hippocampal function and increases BDNF in the serum of young adult males. Physiology and Behavior 2011, 104(5):934-941. 10.1016/j.physbeh.2011.06.005.
36. Grissom R.J., Kim J.J. Effect Sizes for Research: A Broad Practical Approach 2005, Erlbaum, Mahwah, NJ.
37. Grove W.M. When is a diagnosis worth making? A statistical comparison of two prediction strategies. Psychological Reports 1991, 69(1):3-17.
38. Gruber, O., Hasan, A., Scherk, H., Wobrock, T., Schneider-Axmann, T., Ekawardhani, S., Schmitt, A., Backens, M., Reith, W., Meyer, J., Falkai, P., 2012. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system. European Archives Psychiatry Clinical Neurosciences 262, 23-31. http://dx.doi.org/10.1007/s00406-011-0214-6.
39. *Ho B.-C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Archives of General Psychiatry 2006, 63(7):731-740. 10.1001/archpsyc.63.7.731.
40. *Ho B.-C., Andreasen N.C., Dawson J.D., Wassink T.H. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am Journal of Psychiatry 2007, 164:1890-1899. 10.1176/appi.ajp.2007.05111903.
41. Holm S. A simple sequential rejective method procedure. Scandinavian Journal of Statistics 1979, 6:65-70.
42. Hosang, G.M., Uher, R., Keers, R., Cohen-Woods, S., Craig, I., Korszun, A., Perry, J., Tozzi, F., Muglia, P., McGuffin, P., Farmer, A.E., 2010. Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. Journal of Affective Disorders 125, 345-349. http://dx.doi.org/10.1016/j.jad.2010.01.071.
43. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annual Review of Biochemistry 2003, 72:609-642. 10.1146/annurev.biochem.72.121801.161629.
44. Hwang, J.-P., Tsai, S.-J., Hong, C.-J., Yang, C.-H., Lirng, J.-F., Yang, Y.-M., 2006. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiology of Aging 27, 1834-1837. http://dx.doi.org/10.1016/j.neurobiolaging.2005.10.013.
45. Iga, J., Ueno, S., Yamauchi, K., Numata, S., Tayoshi-Shibuya, S., Kinouchi, S., Nakataki, M., Song, H., Hokoishi, K., Tanabe, H., Sano, A., Ohmori, T., 2007. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. American Journal of Medical Genetics B Neuropsychiatric Genetics 144B, 1003-1006. http://dx.doi.org/10.1002/ajmg.b.30520.
46. Islam O., Loo T.X., Heese K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Current Neurovascular Research 2009, 6(1):42-53.
47. Joyce E.M., Roiser J.P. Cognitive heterogeneity in schizophrenia. Current Opinions in Psychiatry 2007, 20(3):268-272.
48. Kambeitz, J.P., Bhattacharyya, S., Kambeitz-Ilankovic, L.M., Valli, I., Collier, D.A., McGuire, P., 2012. Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neuroscience and Biobehavioral Reviews 36, 2165-2177. http://dx.doi.org/10.1016/j.neubiorev.2012.07.002.
49. Kim, B., Kim, C.Y., Hong, J.P., Kim, S.Y., Lee, C., Joo, Y.H., 2008. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients. Neuropsychobiology 58, 97-103. http://dx.doi.org/10.1159/000162356.
50. Koolschijn PCMP, van Haren N.E.M., Bakker S.C., Hoogendoorn M.L.C., Hulshoff Pol H.E., Kahn R.S. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus 2010, 20(9):1010-1017. 10.1002/hipo.20699.
51. Koshimizu H., Kiyosue K., Hara T., Hazama S., Suzuki S., Uegaki K., Nagappan G., Zaitsev E., Hirokawa T., Tatsu Y., Ogura A., Lu B., Kojima M. Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Molecular Brain 2009, 2:27.
52. *Lu W., Zhang C., Yi Z., Li Z., Wu Z., Fang Y. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia. Journal of Molescular Neuroscience 2012, 47(3):505-510. 10.1007/s12031-012-9750-4.
53. Luo J., Niki K. Function of hippocampus in "insight" of problem solving. Hippocampus 2003, 13(3):316-323. 10.1002/hipo.10069.
54. Mandelman S.D., Grigorenko E.L. BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association. Genes, Brain, and Behavior 2012, 11(2):127-136.
55. *Martinho E., Michelon L., Ayres A.M., Scazufca M., Menezes P.R., Schaufelberger M.S., et al. BDNF gene polymorphism, cognition and symptom severity in a Brazilian population-based sample of first-episode psychosis subjects. Revista Brasileira de Psiquiatria 2012, 34(Suppl. 2):S219-S225.
56. Miyajima, F., Ollier, W., Mayes, A., Jackson, A., Thacker, N., Rabbitt, P., Pendleton, N., Horan, M., Payton, A., 2008. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behavior 7, 411-417. http://dx.doi.org/10.1111/j.1601-183X.2007.00363.x.
57. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009, 6(7):e1000097. The PRISMA Group.
58. Molendijk M.L., van Tol M.-J., BWJH Penninx, van der Wee N.J.A., Aleman A., Veltman D.J., et al. BDNF val66met affects hippocampal volume and emotion-related hippocampal memory activity. Translational Psychiatry 2012, 2(1):e74. 10.1038/tp.2011.72.
59. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry 2005, 10(2):208-212. 10.1038/sj.mp.4001575.
60. Nguyen N., Lee S.B., Lee Y.S., Lee Y.S., Lee K.-H., Ahn J.-Y. Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochemical Research 2009, 34(5):942-951. 10.1007/s11064-008-9848-9.
61. *Niitsu T., Shirayama Y., Matsuzawa D., Hasegawa T., Kanahara N., Hashimoto T., et al. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia. Progress in Neuro-psychopharmacology and Biological Psychiatry 2011, 35(8):1836-1840. 10.1016/j.pnpbp.2011.09.004.
62. Numata S., Ueno S.-I., Iga J.-I., Yamauchi K., Hongwei S., Ohta K., et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neuroscience Letters 2006, 401(1-2):1-5. 10.1016/j.neulet.2006.02.054.
63. Paz R.D., Andreasen N.C., Daoud S.Z., Conley R., Roberts R., Bustillo J., Perrone-Bizzozero N.I. Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia. American Journal of Psychiatry 2006, 163(10):1829-1831. 10.1176/appi.ajp.163.10.1829.
64. Perroud, N., Courtet, P., Vincze, I., Jaussent, I., Jollant, F., Bellivier, F., Leboyer, M., Baud, P., Buresi, C., Malafosse, A., 2008. Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes Brain Behavior 7, 314-322. http://dx.doi.org/10.1111/j.1601-183X.2007.00354.x.
65. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Journal of Neuroscience 2004, 24(45):10099-10102. 10.1523/jneurosci.2680-04.2004.
66. Pillai A., Buckley P.F. Reliable biomarkers and predictors of schizophrenia and its treatment. Psychiatric Clinics of North America 2012, 35(3):645-659. 10.1016/j.psc.2012.06.006.
67. Pruunsild P., Kazantseva1 A., Aid T., Palm K., Timmusk T. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007, 90(3):397-406. 10.1016/j.ygeno.2007.05.004.
68. Ray M.T., Shannon Weickert C., Webster M.J. Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders. Translational Psychiatry 2014, 4(5):e389.
69. Ribasés, M., Gratacòs, M., Armengol, L., de Cid, R., Badía, A., Jiménez, L., Solano, R., Vallejo, J., Fernández, F., Estivill, X., 2003. Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Molecular Psychiatry 8, 745-751, http://dx.doi.org/10.1038/sj.mp.4001281.
70. Rosa A., Cuesta M.J., Fatjó-Vilas M., Peralta V., Zarzuela A., Fañanás L. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2006, 141B(2):135-138. 10.1002/ajmg.b.30266.
71. *Rybakowski J.K., Borkowska A., Skibinska M., Szczepankiewicz A., Kapelski P., Leszczynska-Rodziewicz A., et al. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry and Clinical Neurosciences 2006, 60(1):70-76. 10.1111/j.1440-1819.2006.01462.x.
72. Savitz J., Solmsm M., Ramesar R. The molecular genetics of cognition: dopamine, COMT and BDNF. Genes, Brain and Behavior 2006, 5:311-328.
73. Smith G.N., Thornton A.E., Lang D.J., Macewan G.W., Ehmann T.S., Kopala L.C., et al. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis. Schizophrenia Research 2012, 134(2-3):253-259. 10.1016/j.schres.2011.11.022.
74. Takahashi, T., Suzuki, M., Tsunoda, M., Kawamura, Y., Takahashi, N., Tsuneki, H., Kawasaki, Y., Zhou, S.-Y., Kobayashi, S., Sasaoka, T., Seto, H., Kurachi, M., Ozaki, N., 2008. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neuroscience Letters 435, 34-39. http://dx.doi.org/10.1016/j.neulet.2008.02.004.
75. Teng H.K., Teng K.K., Lee R., Wright S., Tevar S., Almeida R.D., Kermani P., Torkin R., Chen Z.Y., Lee F.S., Kraemer R.T., Nykjaer A., Hempstead B.L. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. Journal of Neuroscience 2005, 25(22):5455-5463.
76. Terracciano A., Tanaka T., Sutin A.R., Deiana B., Balaci L., Sanna S., et al. BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism. Neuropsychopharmacology 2010, 35(5):1083-1089. 10.1038/npp.2009.213.
77. Tost H., Alam T., Geramita M., Rebsch C., Kolachana B., Dickinson D., et al. Effects of the BDNF val(66)met polymorphism on white matter microstructure in healthy adults. Neuropsychopharmacology 2013, 38(3):525-532. 10.1038/npp.2012.214.
78. Tsai, S.-J., Hong, C.-J., Yu, Y.W.-Y., Chen, T.-J., 2004. Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 49, 13-16. http://dx.doi.org/10.1159/000075333.
79. Tsuchimine S., Sugawara N., Ishioka M., Yasui-Furukori N. Preanalysis storage conditions influence the measurement of brain-derived neurotrophic factor levels in peripheral blood. Neuropsychobiology 2014, 69(2):83-88. 10.1159/000358061.
80. Van Winkel R., Stefanis N.C., Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophrenia Bulletin 2008, 34(6):1095-1105. 10.1093/schbul/sbn101.
81. Vinogradov S., Fisher M., Holland C., Shelly W., Wolkowitz O., Mellon S.H. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?. Biological Psychiatry 2009, 66(6):549-553. 10.1016/j.biopsych.2009.02.017.
82. *Vyas N.S., Puri B.K. Evidence for an association between brain-derived neurotrophic factor Val66Met gene polymorphism and general intellectual ability in early-onset schizophrenia. Israel Journal of Psychiatry and Related Sciences 2012, 49(2):137-142.
83. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Molecular Psychiatry 2003, 8(6):592-610.
84. Wiener H., Klei L., Calkins M., Wood J., Nimgaonkar V., Gur R., et al. Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects. Schizophrenia Bulletin 2013, 39(2):464-471. 10.1093/schbul/sbr161.
85. Witte, A.V., Kürten, J., Jansen, S., Schirmacher, A., Brand, E., Sommer, J., Flöel, A., 2012. Interaction of BDNF and COMT polymorphisms on paired-associative stimulation-induced cortical plasticity. Journal of Neuroscience 32, 4553-4561. http://dx.doi.org/10.1523/JNEUROSCI.6010-11.2012.
86. Wong J., Hyde T.M., Cassano H.L., Deep-Soboslay A., Kleinman J.E., Weickert C.S. Promoter specific alterations of BDNF mRNA in schizophrenia. Neuroscience 2010, 169(3):1071-1084.
87. Zakharyan R., Boyajyan A. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes. Clinical Biochemistry 2014, 47(12):1052-1055.
88. Zeithamova D., Schlichting M.L., Preston A.R. The hippocampus and inferential reasoning: building memories to navigate future decisions. Frontiers in Human Neuroscience 2012, 6:70. 10.3389/fnhum.2012.00070.
89. *Zhang X.Y., Chen D.C., Xiu M.H., Haile C.N., Luo X., Xu K., et al. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Human Genetics 2012, 131(7):1187-1195. 10.1007/s00439-012-1150-x.
90. *Zhang X.Y., Liang J., Chen D.C., Xiu M.H., Yang F.D., Kosten T.A., Kosten T.R. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology 2012, 222(2):277-284. 10.1007/s00213-012-2643-y.